Amgen Ventures — 2022 Investments
5 investments dated 2022 · listed companies and verified rows first · show all
Big Hat Bio develops therapeutics under development across multiple programs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Peyton Greenside(Founder)inMark DePristo(Founder)inMark DePristo Peyton Greenside(Founder)Theresa Tribble(Founder)Andrew Conrad(Director)
BoardFrancisco Gimenez(Director)in
Co-investors8VCAndreessen HorowitzBOLD LongevityCatalio Capital Management, LPFlucas VenturesGaingels+16 more
Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.
BiotechDeep TechHealthtechHatfield, US
Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)Brian McVeigh(Executive Officer, Director)in
BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)
Co-investorsNew Enterprise Associates (NEA)4BIO CapitalHatteras Venture PartnersJDRF T1D FundNorthpond VenturesTakeda Ventures+1 more
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.
AI & Machine LearningBiotechDeep TechDigital Health
Sriram Subramaniam(Founder)in
Co-investorsLux CapitalObvious VenturesAmplitude Venture CapitalLeaps by Bayer
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Co-investorsadMare BioInnovationsAmorChemGenesys CapitalJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla Ventures+2 more
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)Burak YILMAZ(Founder)in
Co-investorsAmino CollectiveAsymmetry VenturesCivilization Ventures Management, LlcFoundersX VenturesGaingelsHOF Capital+14 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







__Twitter.png)


















